MedPAC Plans Deep Dive Into Part D, Drug Pricing

Congress' Medicare payment advisers are planning a deep dive into the Part D program and drug prices as the president-elect continues to signal a need for drug negotiation in Medicare. But some commissioners are concerned the Medicare Payment Advisory Commission isn't taking rising Part D drug prices seriously enough and say it should look into setting or capping the price for sole-source drugs or negotiating those prices. Some commissioners also expressed interest in weighing value-based purchasing and limits on covering...